The GSK-3/beta-catenin-signalling axis in smooth muscle and its relationship with remodelling
about
Glycogen synthase kinase 3 beta positively regulates Notch signaling in vascular smooth muscle cells: role in cell proliferation and survivalHDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activationAsthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?ß-Catenin is markedly induced in a murine model of an arteriovenous fistula: the effect of metalloproteinase inhibitionTGF-β-activated kinase 1 (TAK1) signaling regulates TGF-β-induced WNT-5A expression in airway smooth muscle cells via Sp1 and β-catenin.Insulin and the lung: connecting asthma and metabolic syndrome.The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function.Noncanonical WNT-5B signaling induces inflammatory responses in human lung fibroblasts.Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstructive pulmonary disease.WNT3A induces a contractile and secretory phenotype in cultured vascular smooth muscle cells that is associated with increased gap junction communication.β-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition.{beta}-Catenin regulates airway smooth muscle contraction.Going with the Wnt? Focus on "Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC".The antimicrobial protein S100A7/psoriasin enhances the expression of keratinocyte differentiation markers and strengthens the skin's tight junction barrier.Influence of protein kinase RIPK4 expression on the apoptosis and proliferation of chondrocytes in osteoarthritis.
P2860
Q28583993-9BC81B45-776A-45FC-A881-64DAE92A6486Q33891516-C9C97BF5-7AAA-4DEE-8415-D27BE87EFC98Q34235628-9A4F9800-D0A4-4F8E-B916-5CD865E41112Q34426335-4BB0DA4E-7DDC-4A92-B246-CA228255F0EEQ35146881-077F9E22-C2AD-4711-92B5-D8DFD648DF6AQ37239619-7BCDFAD2-1D30-4F07-B936-C3064F00ACF9Q37632467-EDAA6A45-3C35-4F0E-8599-82B0A8E184F8Q38781496-CFAA0163-843F-40C2-83AE-880DF46261A3Q39201336-1EA68033-46EF-4253-A527-91177E599A76Q39439149-ACD03035-9AC5-4CF1-B4DB-F7B4B8A49D28Q39454012-E5475CBA-4D4B-4613-A988-61A5606CADFCQ43062306-922E1B62-A150-4C7D-8322-7EBCD9D3CF7BQ45954140-63FE4367-7F2B-48BD-9CB1-F41F6146120EQ46220466-9C1DC503-D7C1-4C6D-9B09-C7C2D8917C94Q47276085-6F944946-9096-4D93-8D54-D23D69E679CC
P2860
The GSK-3/beta-catenin-signalling axis in smooth muscle and its relationship with remodelling
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The GSK-3/beta-catenin-signall ...... relationship with remodelling
@en
The GSK-3/beta-catenin-signall ...... relationship with remodelling.
@nl
type
label
The GSK-3/beta-catenin-signall ...... relationship with remodelling
@en
The GSK-3/beta-catenin-signall ...... relationship with remodelling.
@nl
prefLabel
The GSK-3/beta-catenin-signall ...... relationship with remodelling
@en
The GSK-3/beta-catenin-signall ...... relationship with remodelling.
@nl
P2093
P2860
P921
P1476
The GSK-3/beta-catenin-signall ...... relationship with remodelling
@en
P2093
Herman Meurs
Martina Schmidt
Reinoud Gosens
P2860
P2888
P304
P356
10.1007/S00210-008-0269-8
P577
2008-07-09T00:00:00Z
2008-08-01T00:00:00Z